4 Geographic Atrophy Clinical Trials in Newark, NJ (2026)

Q: How do I join a clinical trial in Newark?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Newark research site will contact you.

Recruiting Geographic Atrophy Studies in Newark

NCT06926868Recruiting

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase inhibitor payload versus treatment of physi...

Newark, NJ500 participantsBristol-Myers Squibb

View Study Details

NCT07069712Recruiting

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

GEMINI-PeriOp GC study will assess the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity of novel agents or novel combinations as perioperative treatment in participants ...

Newark, NJ100 participantsAstraZeneca

View Study Details

NCT05801861Recruiting

Modulating Goal-directed Navigation Using Noninvasive Brain Stimulation

Our specific aim is to examine the effects of TMS on spatial processing during goal-directed navigation. In these experiments the investigators will utilize a scalp-recorded brain oscillation called r...

Newark, NJ60 participantsRutgers, The State University of New Jersey

View Study Details

NCT05332002Recruiting

sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)

The primary objective is to determine the clinical efficacy of treatment regimen in terms of objective response rate (ORR). The secondary objectives is to determine the clinical efficacy of the study ...

Newark, NJ38 participantsRutgers, The State University of New Jersey

View Study Details

About Geographic Atrophy Clinical Trials in Newark

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 4 geographic atrophy clinical trials recruiting participants in Newark, NJ. These studies are seeking a combined 698 participants. Research is being sponsored by Bristol-Myers Squibb, AstraZeneca, Rutgers, The State University of New Jersey. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Newark — FAQ

Are there geographic atrophy clinical trials in Newark?

Yes, there are 4 geographic atrophy clinical trials currently recruiting in Newark, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Newark?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newark research site will contact you about next steps.

Are clinical trials in Newark free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newark studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 4 active trials in Newark are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated July 13, 2026 from ClinicalTrials.gov